For decades, scientists believed molecules called leukotrienes were the main culprits behind asthma’s airway-constricting inflammation. But new research suggests that “pseudo leukotrienes” may ...

Thomas Jefferson University scientist Raymond Penn spends his days searching for the molecules that could be the key to better asthma treatments. He’s invested decades into this goal, for which stakes ...

An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...

"Chiesi drops COPD and asthma asset after Phase III miss" was originally created and published by Clinical Trials Arena, a ...

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by a University of ...

Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at $35 per month, a move that offers relief but doesn't fully address the larger issue of high drug costs ...

People taking GLP-1 medications had better-controlled asthma overall, though there was no difference in lung function compared to those not taking GLP-1s. The study suggests that GLP-1 drugs may have ...

Learn about common asthma triggers, from dust mites to food allergens, that may be hiding in your child’s backpack, and ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

New research is the latest to find that thunderstorms can worsen your odds of a serious seasonal asthma attack.